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ABSTRACT
Introduction: The optimal approach to engage the
public in healthcare decision-making is unclear.
Approaches range from deliberative citizens’ juries to
large population surveys using discrete choice
experiments. This study promotes public engagement
and quantifies preferences in two key areas of relevance
to the industry partners to identify which approach is
most informative for informing healthcare policy.
Methods and analysis: The key areas identified are
optimising appropriate use of emergency care and
prioritising patients for bariatric surgery. Three citizens’
juries will be undertaken—two in Queensland to address
each key issue and one in Adelaide to repeat the bariatric
surgery deliberations with a different sample. Jurors will be
given a choice experiment before the jury, immediately
following the jury and at approximately 1 month following
the jury. Control groups for each jury will be given the
choice experiment at the same time points to test for
convergence. Samples of healthcare decision-makers will be
given the choice experiment as will two large samples of
the population. Jury and control group participants will be
recruited from the Queensland electoral roll and newspaper
advertisements in Adelaide. Population samples will be
recruited from a large research panel. Jury processes will be
analysed qualitatively and choice experiments will be
analysed using multinomial logit models and its more
generalised forms. Comparisons between preferences
across jurors predeliberation and postdeliberation, control
participants, healthcare decision-makers and the general
public will be undertaken for each key issue.
Ethics and dissemination: The study is approved by
Griffith University Human Research Ethics Committee
(MED/10/12/HREC). Findings of the juries and the choice
experiments will be reported at a workshop of stakeholders
to be held in 2015, in reports and in peer reviewed journals.
INTRODUCTION
The Organisation for Economic Cooperation
and Development (OECD) has recognised the
importance of engaging citizens in policy-
making.1 Greater participation by citizens can:
▸ Increase the chances of successful imple-
mentation of a policy;
▸ Reinforce the legitimacy of the decision-
making process and its ﬁnal results;
▸ Increase the chance of voluntary
compliance;
▸ Increase the scope for partnerships with
citizens.
Public participation in decision-making can
be used in healthcare and for all public goods
and services—and is most valuable when used
to inform difﬁcult decisions about priority
setting and resource allocation.1 Some coun-
tries, such as the UK, now routinely seek the
views of local people and communities in the
assessment of health services and interven-
tions when setting healthcare priorities.2 In
Australia, the National Health and Hospitals
Reform Commission has recommended that
a systematic mechanism be developed to for-
mulate healthcare priorities that incorporate
community perspectives as well as economic
and clinical considerations.3
There are various approaches to seeking
the views of the public to inform healthcare
decisions. At one end of the spectrum there
are deliberative approaches informed by
experts, such as citizens’ juries (CJs), in the
middle there are lobby groups and consumer
representatives in various participatory roles,
and at the other end of the spectrum there
are referenda where the public vote to either
accept or reject a proposal. Less inclusive
approaches are opinion surveys of popula-
tion samples, however, advanced forms of
opinion surveys seek to elicit preferences
around the attributes that can inﬂuence
acceptance or rejection of a policy proposal.
The CJs as a deliberative method for
engaging the public
In a CJ, a sample of the public are presented
with a dilemma about which experts present
evidence and are cross-examined by jurors.
CJs, as with legal juries, are based on the
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idea that once a small sample of the population has
heard the evidence, its subsequent deliberations can
fairly represent the conscience and intelligence of the
general public.4 5 CJs are now routinely used by the
UK’s National Institute for Health and Care Excellence
(NICE) for health policy guidance, and elsewhere.6 7
There is evidence that jurors become actively engaged
in debates, express their views, are able to recall ﬁne
details about the information presented and, subse-
quently, develop a sense of community, shifting their
views from self-interested to socialistic.4–7 However, until
now, the processes and mechanisms of CJs have been
explored qualitatively and there is a need to capture the
relative strength of preferences of the individual
members of a CJ as well as their consensus opinion.
Discrete choice experiments (DCEs) to quantify public
preferences for healthcare
CJs do not quantify preferences surrounding healthcare
decisions. Quantiﬁcation of the strength of preference
and the trade-offs participants are willing to make between
different alternatives before them is important as this
information contextualises decision-making. Discrete
choice experiments (DCEs) typically involve the presenta-
tion of a series of choices between two or more alternative
scenarios, each representing a unique combination of spe-
ciﬁed attributes and levels of the treatment or service
under consideration.8 9 Statistical analysis of the indivi-
duals’ choices identiﬁes the relative importance of the
attributes and the trade-offs individuals make when choos-
ing one scenario over another, (ie, the amount of one
attribute they are prepared to forgo to have more of
another). Thus, DCEs are a useful approach for quantify-
ing attributes and trade-offs in large samples of the public
and can be used in small discrete groups. This study will
use DCEs concurrently with CJs in large samples of the
public and other relevant discrete groups.
Objective
This paper describes the study protocol of a trial of two
distinct processes for engaging the public in healthcare
decisions. The speciﬁc aims of the study are to:
1. Determine the preferences of the public for govern-
ment expenditure in two key areas of healthcare
using DCEs and CJs;
2. Assess the effect of deliberations in the CJ on prefer-
ences for healthcare using DCEs;
3. Assess the test–retest reliability (stability) of prefer-
ences elicited from DCEs;
4. Identify and evaluate the discursive processes that
characterise CJs;
5. Identify the correlation between preferences of jurors
after deliberations, and healthcare decision-makers.
METHODS AND ANALYSIS
A mixed methods approach to eliciting public input for
healthcare decision-making will be used. The study will
adopt qualitative (CJ processes) and quantitative (DCE)
approaches. Following consultation with the industry
partners, two key areas of relevance were identiﬁed for
this study; namely how to optimise use of emergency
care and prioritising patients for bariatric surgery. For
each key area, a CJ will be conducted and DCEs under-
taken in the jurors, a control group, healthcare decision
makers and a large sample of the general public.
Health topics for the study
1. Optimising appropriate use of emergency care: emergency
department (ED) crowding is a global as well as national
challenge. If unchecked, it can result in poor health out-
comes.10 11 Strategies to address crowding can be found
at all levels of the health system from prehospital to
community care.10 11 The problem of crowding in EDs is
not independent of the challenge of reducing elective
surgery waits, as both result in competition for inpatient
beds.11 Public input into the planning, promotion and
implementation of strategies to reduce the inappropriate
utilisation of EDs and the allocation of resources to
address crowding would contribute to efﬁcient and
responsive policy in this area. The DCE will quantify
trade-offs the public is prepared to make between the
key characteristics of an emergency service differentiated
according to the severity of condition (eg, waiting times,
clinician versus nurse led consultations, service location,
hospital or primary care clinic setting) which will inform
the development of strategies for optimising appropriate
ED utilisation.
2. Prioritising patients for bariatric surgery: The increasing
prevalence and health and economic burden associated
with obesity are well established.12 13 A range of inter-
ventions are available to reduce obesity, some of which
have good evidence supporting their effectiveness.14
There are a number of controversial issues for deliber-
ation around this elective surgery (eg, what criteria
should be used to prioritise access? Should any popula-
tion subgroup/s receive priority?) A DCE will be
designed to quantify the relative importance of and
implied trade-offs between priority-setting criteria for
surgical management of obesity.15–17
Refining the topics for study
Key staff members from Queensland Health (QH) will
be selected to form focus groups. One focus group will
be held for each topic, with different staff members
being selected to participate in each group. The lead
partner investigators in QH will nominate approximately
15 staff for each focus group, according to their expert-
ise and experience in the broad topic area. The focus
groups will develop speciﬁc questions to be addressed by
the CJs and DCEs. These questions will be reviewed and
amended as necessary by the partner investigator to
ensure they have direct policy relevance. The focus
groups will be conducted using the nominal group tech-
nique (NGT) which is a multistage method designed to
assist a group to reach agreement about issues and key
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priorities in order of importance.18 19 The NGT process
begins with nomination by individuals of key issues that
affect a particular area, group discussion for clariﬁcation
and reﬁnement followed by a structured ranking and
voting task in which participants individually select their
top ﬁve issues. Further discussion elucidates the details
contained within each issue, enabling attributes and
levels to be understood and articulated during analysis.
This method meets the recommendations of the
International Society for Pharmacoeconomics and
Outcomes Research as outlined in the Good Research
Practices for Conjoint Analysis Task Force as will be dis-
cussed later.20
The jury process
One jury will be selected to address each health issue.
Both issues will be deliberated using a CJ in Queensland
and one CJ will be developed in South Australia (SA) to
assess consistency in a different sample. The jury process
will be closely aligned with the process espoused by the
Jefferson Center,21 including juror selection, witness
selection, providing the jury with a ‘charge’ (task facing
the jury), planned hearings, breakout periods for delib-
erations and deliberative period for developing
recommendations.
Samples of approximately 20 members of the general
public will be recruited for each CJ. Expert witnesses will
include patients and/or carers, clinicians, health profes-
sionals (eg, doctors, nurses and allied health) and
health service managers. These witnesses will be identi-
ﬁed and provided by the partner investigators to cover
the ﬁelds of expertise for each topic in Queensland and
SA. With a facilitator, the jury will be charged with their
task, and hear and question expert witnesses presenting
evidence on the relevant topic. Warm-up exercises,
ground rules, introduction to the topic and background
will be covered in an initial session. Scenarios about the
topic will be presented to the jurors for a priority-setting
ranking exercise. Following this exercise, expert wit-
nesses will present their view on the topic and jurors will
question each witness following their presentation. Small
groups of 3–4 members will engage in discussions
around focused questions including the criteria for pri-
ority setting. A set of recommendations on priorities will
be developed from each CJ, and these recommendations
will be presented to the partner organisations.
The DCEs
A DCE will be developed for each deliberative issue.
This will be presented to four independent groups: (1)
the jurors; (2) a control group; (3) a group of decision-
makers and (4) a large random sample of the general
public. DCEs will be presented to these four groups in
Queensland and to the jurors, decision-makers and
general public in SA. This will enable comparisons
between different populations (ﬁgure 1).
Each juror will undertake the DCE immediately prior
to start of the jury to measure the strength of their
personal preferences. The same DCE will be presented
to the jurors at the end of the jury, and at approximately
1 month following the jury to determine if preferences
have changed. Using the same sampling frame used to
select jurors (see below), a group of individuals not
involved in the deliberations will also be given the DCE
at the same time points. This will determine test–retest
reliability of the DCE without the intervening deliber-
ation and identify any effects of ‘learning’ to be
accounted for when analysing preferences. A sample of
decision-makers, such as clinicians or budget holders
will be given the same DCE at the same time points. A
larger and wider representative population-based sample
will also be presented with the DCE using a web-based
survey format to ascertain the preferences of the general
public. Overall, this series of DCEs will enable compari-
sons to be made between the juries, individual consu-
mers, the general public and decision-makers in two
Australian states.
Development of the DCEs
Guidelines on DCEs outline the key principles for good
practice in eliciting preferences using DCEs.8 22 There
are four key steps in developing a DCE:
1. Selection of attributes: The NGT process described
above will be used to reach consensus in samples of the
health-informed population (ie, n=12 health profes-
sionals/general public per group) about the key factors
(attributes) associated with each problem area. Once
the attributes for each issue are identiﬁed they will be
ranked in order of priority.23
2. Reﬁning attributes and levels: Discussion facilitated
during the NGT will be used to conﬁrm attributes and
levels, establish the levels of each attribute and develop
consumer friendly wording which will be used in the
DCE.
3. Experimental design of the DCE: Subject to the
outcome of the NGT, respondents will be asked to
imagine they are the decision-makers for allocating
resources to address a health problem within the next
year, and to choose between two options. Various attri-
butes and levels will form the basis of the self-completed
DCE questionnaire. An illustrative example of a choice
that could be used to develop priorities related to elect-
ive surgery is illustrated in table 1.
An optimal experimental design will be generated for
the DCE to maximise the D-efﬁciency and minimise
SDs8 22; a main effects fractional factorial design will be
used for the small samples (eg, jurors) and a ‘blocked’
full factorial design for the large population sample (ie,
several versions of smaller choice sets will be developed
and respondents will be randomly assigned to each
version). One of these blocks will be the main effects
block, identical to the DCE for the smaller samples, to
enable testing of consistency of preferences between
jurors and the general population when presented with
same choice scenarios. The ﬁnal DCE design will
depend on the ﬁnal number of attributes and levels.
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4. Piloting the questionnaire: The DCE will be piloted to
inform the design and administration of the main
survey.
Sample size
Each jury will consist of 20 jurors; this is the minimum
recommended sample size to undertake an analysis of
main effects of a DCE using methods such as multi-
nomial logit modelling.8 Sample sizes of approximately
20 for the control groups and for the healthcare profes-
sionals/decision-makers will also be used. For the large
general population DCE, the number of attributes and
levels within the full-factorial experimental design will
determine the sample size required. Thus, the ﬁnal
number of participants for this DCE cannot be speciﬁed
exactly until the DCE is deﬁned. Based on the adult
population of Australia and assuming evenly divided pre-
ferences, a sample of 500 has a margin of error (MoE)
of 4.4% that decreases as sample size increases; a sample
of 3000 has a MoE of 1.8%.24 Owing to the relative ease
of web-based recruitment, this will continue throughout
the study until the minimum sample necessitated by the
design of the DCE is achieved. For each DCE, at least
2000 respondents will be recruited to ensure sociodemo-
graphic representativeness relative to the general
Australian population.
Recruitment
A combination of random sampling and purposive sam-
pling will be used.6 Each jury will have different jurors.
Based on response rates of 2–25%, to obtain a represen-
tative sample of 20 jurors in Queensland and another 20
as a control group, 4000 people will be randomly
sampled from the electoral roll in Queensland for the
CJs in Queensland and those who respond to newspaper
advertisements in Adelaide, SA.
For the jurors, a letter of invitation, jury explanation,
jury dates and questionnaire to screen for basic
Figure 1 Study design for each issue deliberated.
Table 1 Example of a discrete choice experiment for bariatric surgery
Individual A Individual B
Current level of obesity Obesity (BMI 30 to less than
40 kg/m2)
Very severe obesity (BMI greater than
50 kg/m2)
Diagnosed with type 2 diabetes No Yes
Age of person needing surgery (years) 50 35
Effectiveness of surgery for weight loss at
2 years (%)
70 50
Failure to respond to prescribed lifestyle
intervention
No Yes
Time spent on waiting list 2 years 6 months




BMI, body mass index.
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demographic factors will be sent to the identiﬁed
person. The questionnaire will seek age, gender, ethni-
city, education, income, employment status, number and
age of dependents and afﬁliations with special interest
groups (exclusion) or employment as a healthcare pro-
fessional (exclusion). To reduce volunteer bias, a sitting
fee will be offered (in addition to travel and accommo-
dation expenses) to jurors. On return of the surveys, eli-
gible respondents will be categorised into groups to
approximate the demographic proﬁle of Queensland.
Where there is more than one case for each demo-
graphic category, the participant will be randomly
selected from that category. Those not selected for the
initial jury may be selected for the DCE control group
or for a subsequent jury. The DCE-only control group
will be purposively selected and a 100% response rate
will be important; therefore, they will be incentivised on
a ﬁxed fee basis for returning their surveys.
For the piloting of the DCEs, convenience samples
will be recruited from staff and students at Grifﬁth
University through local advertising and incentives. The
ﬁnal DCEs will be sent to identiﬁed decision-makers and
key clinical staff in QH and SA Health. The DCEs will also
be sent to a large sample of the general population
through a web-based survey. Although there is potential
for selection bias in web-based surveys, bias between vari-
ables in preference elicitation studies is minimal and
general population panel-based web surveys have been
shown to be valid and reliable.25 26 Email invitation will be
sent to a stratiﬁed sample from PureProﬁle (http://www.
pureproﬁle.com/au). PureProﬁle is an opinion seeking
company with a large panel of research participants.
Analysis of the data
Qualitative analysis
The CJ will be analysed qualitatively to assess discourse
within the jury process and experiences of jurors.
Thematic and discursive analysis will be employed to
examine the qualitative data (ie, transcribed recordings
of jury deliberations and interviews with a purposively
selected sample of jurors from each CJ prior to and fol-
lowing deliberations). Multiple waves of coding will be
applied by at least two independent coders to increase
integrity. As thematic analysis is open to interpretation, a
systematic process will be used for (1) initial coding of
verbatim transcripts at the paragraph level, (2) cluster-
ing of codes to develop concepts, (3) developing themes
from concepts to explain the majority and (4) explain-
ing deviations. Several critical frameworks will be
applied to these themes. First, data will be organised
according to a matrix, enabling data to be compared
across time, topics and populations. Given the import-
ance of change over time in this study, process mapping
will be used.27 Process mapping is a simple tool often
used in the service improvement area to capture a
journey or movement over time (planning and decision-
making processes, change in juror experiences). Maps
also identify constraints, pathways and triggers and can
document change by comparing maps generated at dif-
ferent points in time or place. Semistructured interviews
with jurors will examine experiences of the CJs, capacity
to engage, decision-making processes and changes in
beliefs about healthcare. A benchmark for this qualitative
data, including its limitations, has been set by the NICE
deliberations and evaluation.4 Finally, a feedback ques-
tionnaire with a Likert scale will be developed for jurors
to complete at the end of the jury session; this will
explore issues such as the difﬁcultly of the task, the
number of witnesses, the scope and depth of information
presented and usefulness of small discussion groups.
Statistical analyses
Data from the DCE will be analysed using dichotomous
choice models such as mixed logit regression or generalised
multinomial logit. Mixed logit models allow for correlation
of error components within subjects, as well as correlation
between alternatives where there is more than one alterna-
tive. Mixed logit also allows for unobserved heterogeneity
that can be examined by specifying random parameters (ie,
separate coefﬁcients for each individual).28
Marginal rates of substitution (MRS), calculated as the
ratio of attribute coefﬁcients, will be used to assess the
relative importance of the attributes and the trade-offs
respondents are willing to make between attributes for
gains in another attribute. Preferences will be compared
across discrete choice models (eg, decision-makers vs
public, prejury vs postjury) using two methods: (1) using
correlations of the model coefﬁcients29 and (2) by com-
paring the predicted MRS between attributes.
Ethics and dissemination
Funding was awarded by the Australian Research
Council through a Linkage Grant (#LP100200446), with
ﬁnancial contributions from QH and SA Health.
Findings of the juries and the choice experiments will
be reported at a workshop of stakeholders to be held in
2015, reports to the funding partners, conference pre-
sentations and in peer reviewed journals.
Outcomes from this research include direct recom-
mendations for priority setting from the deliberations of
the juries on the three critical issues under consider-
ation. It will also provide recommendations and knowl-
edge about the processes of consumer engagement
which challenge many governments across the world.
Although CJs are used in the UK and Canada, use of
CJs for healthcare in Australia is relatively limited.30 It is
unclear as to whether this method would work in more
dispersed urban and rural settings as are found in
Australia. This study provides substantial impetus for the
development of a systematic consumer engagement
framework for healthcare priority setting. In the long-
term, this project will have a substantial impact on pro-
cesses of decision-making, priority setting and public
participation in Australia.
This study is one the ﬁrst to combine DCE methods
with a CJ. Studies on consumer input into decision-
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making have adopted either a qualitative or quantitative
approach31; the use of both approaches is a logical, but
to date underutilised, combination. An innovative com-
ponent of this study is to undertake DCEs on members of
a CJ before the jury meet, and then after deliberations to
explore the effect of the CJ process on preferences and
choices. This design will allow us to determine whether
the preferences of individuals in isolation lead to the
same decision made following an interactive group
process. Moreover, it will allow us to compare preferences
and decisions made before and after participants are
fully informed about these complex issues. Thus, we will
be able to make conclusions about the impact of informa-
tion and its presentation on preferences.
Very few studies have compared decision-makers’
choices with those of the general public.32 This study
will systematically undertake comparisons to identify
whether decision-makers adequately represent the views
of the public. Finally, the study will test the utility and
reliability of the DCE over time, which is essential to the
validation of its use in this context.
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